Published in Cell Calcium on May 01, 2001
Purinergic signalling and cancer. Purinergic Signal (2013) 1.18
P2 receptors and neuronal injury. Pflugers Arch (2006) 1.18
P2Y1 and P2Y13 purinergic receptors mediate Ca2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells. Am J Physiol Cell Physiol (2010) 0.92
Modulation/physiology of calcium channel sub-types in neurosecretory terminals. Cell Calcium (2012) 0.89
Mechanically induced intercellular calcium communication in confined endothelial structures. Biomaterials (2013) 0.85
Dynamic remodelling of synapses can occur in the absence of the parent cell body. BMC Neurosci (2007) 0.83
Inseparable tandem: evolution chooses ATP and Ca2+ to control life, death and cellular signalling. Philos Trans R Soc Lond B Biol Sci (2016) 0.82
Actin filaments play a permissive role in the inhibition of store-operated Ca2+ entry by extracellular ATP in rat brown adipocytes. Biochem J (2004) 0.79
Podocyte Purinergic P2X4 Channels Are Mechanotransducers That Mediate Cytoskeletal Disorganization. J Am Soc Nephrol (2015) 0.76
Photobiomodulation therapy reduces apoptotic factors and increases glutathione levels in a neuropathic pain model. Lasers Med Sci (2016) 0.75
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463. Kidney Int (2000) 4.43
Inhibition of oxytocin receptor function by direct binding of progesterone. Nature (1998) 2.54
The role of patterned burst and interburst interval on the excitation-coupling mechanism in the isolated rat neural lobe. J Physiol (1985) 2.24
Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol (2012) 1.63
Hormone release from isolated nerve endings of the rat neurohypophysis. J Physiol (1987) 1.62
Evidence for a direct negative coupling between dopamine-D2 receptors and PLC by heterotrimeric Gi1/2 proteins in rat anterior pituitary cell membranes. Endocrinology (2002) 1.48
Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth (2001) 1.43
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol (1986) 1.43
The relationship among carbon dioxide pneumoperitoneum, vasopressin release, and hemodynamic changes. Anesth Analg (1999) 1.34
A rise in the intracellular Ca2+ concentration of isolated rat supraoptic cells in response to oxytocin. J Physiol (1994) 1.32
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest (1996) 1.28
An R-type Ca(2+) current in neurohypophysial terminals preferentially regulates oxytocin secretion. J Neurosci (1999) 1.17
Requirements for hormone release from permeabilized nerve endings isolated from the rat neurohypophysis. J Physiol (1987) 1.16
Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. J Biol Chem (1986) 1.11
Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors. Mol Pharmacol (1978) 1.10
Interaction of SNX482 with domains III and IV inhibits activation gating of alpha(1E) (Ca(V)2.3) calcium channels. Biophys J (2001) 1.10
Depolarization-induced Ca2+ increase in isolated neurosecretory nerve terminals measured with fura-2. Proc Natl Acad Sci U S A (1987) 1.09
ATP-evoked increases in [Ca2+]i and peptide release from rat isolated neurohypophysial terminals via a P2X2 purinoceptor. J Physiol (1998) 1.08
Activation of polyphosphoinositide phospholipase C by fluoride in WRK1 cell membranes. FEBS Lett (1986) 1.04
ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4) is a new acute-phase protein isolated from cattle during experimental infection. Infect Immun (2004) 1.03
The concentration of apolipoprotein A-I decreases during experimentally induced acute-phase processes in pigs. Infect Immun (2005) 1.00
Positive feedback regulation of phospholipase C by vasopressin-induced calcium mobilization in WRK1 cells. Cell Signal (1990) 1.00
Stimulation, by vasopressin and other agonists, of inositol-lipid breakdown and inositol phosphate accumulation in WRK 1 cells. Biochem J (1986) 0.98
Characterization of the regulatory domain of gizzard calponin. Interactions of the 145-163 region with F-actin, calcium-binding proteins, and tropomyosin. J Biol Chem (1995) 0.98
Role of Q-type Ca2+ channels in vasopressin secretion from neurohypophysial terminals of the rat. J Physiol (1997) 0.96
Activation of membrane phospholipase C by vasopressin. A requirement for guanyl nucleotides. FEBS Lett (1986) 0.96
T-type calcium currents in rat cardiomyocytes during postnatal development: contribution to hormone secretion. Am J Physiol Heart Circ Physiol (2000) 0.96
Genomic and non-genomic mechanisms of oxytocin receptor regulation. Adv Exp Med Biol (1998) 0.95
Close association of the alpha subunits of Gq and G11 G proteins with actin filaments in WRK1 cells: relation to G protein-mediated phospholipase C activation. Proc Natl Acad Sci U S A (1995) 0.94
Possible role during exocytosis of a Ca(2+)-activated channel in neurohypophysial granules. Neuron (1992) 0.93
Activation of alpha-1A adrenoceptors mobilizes calcium from the intracellular stores in myocytes from rat portal vein. J Pharmacol Exp Ther (1994) 0.92
Osmoregulation of vasopressin secretion via activation of neurohypophysial nerve terminals glycine receptors by glial taurine. J Neurosci (2001) 0.92
Mutation of Asn-391 within the conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor. J Biol Chem (2000) 0.92
L-, N- and T- but neither P- nor Q-type Ca2+ channels control vasopressin-induced Ca2+ influx in magnocellular vasopressin neurones isolated from the rat supraoptic nucleus. J Physiol (1997) 0.92
Do opioid peptides modulate, at the level of the nerve endings, the release of neurohypophysial hormones? Exp Brain Res (1986) 0.92
High yield photoaffinity labeling of angiotensin II receptors. Mol Pharmacol (1986) 0.91
Developmental regulation of a local positive autocontrol of supraoptic neurons. J Neurosci (2000) 0.90
Release of neuropeptides does not only occur at nerve terminals. Biosci Rep (1988) 0.90
A systematic study of effects of non-ionic detergens on solubilization and activity of pig kidney adenylate cyclase. Eur J Biochem (1978) 0.90
Isolated neurosecretory nerve endings as a tool for studying the mechanism of stimulus-secretion coupling. Biosci Rep (1987) 0.90
Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes. Curr Opin Pharmacol (2009) 0.89
Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity. Am J Physiol (1988) 0.89
Rapid inhibition of Ca2+ influx by neurosteroids in murine embryonic sensory neurones. Cell Calcium (2006) 0.88
Relaxin affects the release of oxytocin and vasopressin from the neurohypophysis. Nature (1987) 0.88
Receptor-oriented intercellular calcium waves evoked by vasopressin in rat hepatocytes. EMBO J (1998) 0.88
Control of conformational equilibria in the human B2 bradykinin receptor. Modeling of nonpeptidic ligand action and comparison to the rhodopsin structure. J Biol Chem (2001) 0.87
Kinetic and pharmacological characterization of vasopressin membrane receptors from human kidney medulla: relation to adenylate cyclase activation. Eur J Pharmacol (1982) 0.87
Comparative involvement of cyclic nucleotide phosphodiesterases and adenylyl cyclase on adrenocorticotropin-induced increase of cyclic adenosine monophosphate in rat and human glomerulosa cells. Endocrinology (1999) 0.87
[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors. Endocrinology (2002) 0.86
New aspects of firing pattern autocontrol in oxytocin and vasopressin neurones. Adv Exp Med Biol (1998) 0.85
Vasopressin regulates adrenal functions by acting through different vasopressin receptor subtypes. Adv Exp Med Biol (1998) 0.85
Inhibition of hormonally regulated adenylate cyclase by the beta gamma subunit of transducin. EMBO J (1985) 0.85
Chronic osmotic stimuli increase salusin-beta-like immunoreactivity in the rat hypothalamo-neurohypophyseal system: possible involvement of salusin-beta on [Ca2+]i increase and neurohypophyseal hormone release from the axon terminals. J Neuroendocrinol (2007) 0.84
Hormone-dependent desensitization of vasopressin-sensitive adenylate cyclase. Biochem Biophys Res Commun (1976) 0.84
Calcium channel subtypes responsible for voltage-gated intracellular calcium elevations in embryonic rat motoneurons. Neuroscience (1998) 0.84
Physiological studies of stress responses in the hypothalamus of vasopressin-enhanced green fluorescent protein transgenic rat. J Neuroendocrinol (2007) 0.84
Ethanol reduces vasopressin release by inhibiting calcium currents in nerve terminals. Brain Res (1991) 0.84
V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones. J Physiol (1999) 0.84
Vasopressin receptors in human adrenal medulla and pheochromocytoma. J Clin Endocrinol Metab (1999) 0.84
Activation of multiple intracellular transduction signals by vasopressin in vasopressin-sensitive neurones of the rat supraoptic nucleus. J Physiol (1998) 0.83
Characterization of K+ and Ca2+ ionic currents in glomerulosa cells from human adrenal glands. Endocrinology (1994) 0.83
Glucocorticoids rapidly inhibit oxytocin-stimulated adrenocorticotropin release from rat anterior pituitary cells, without modifying intracellular calcium transients. Endocrinology (1993) 0.83
Characterization of a G protein-activated phosphoinositide 3-kinase in vascular smooth muscle cell nuclei. J Biol Chem (2001) 0.83
Tolerance to acute ethanol inhibition of peptide hormone release in the isolated neurohypophysis. Alcohol Clin Exp Res (2000) 0.83
Comparison of the developmental patterns of vasopressin, glucagon and alpha-adrenergic receptors from rat-liver membranes. Mol Cell Endocrinol (1980) 0.83
Distribution of signaling molecules involved in vasopressin-induced Ca2+ mobilization in rat hepatocyte multiplets. J Histochem Cytochem (1999) 0.83
Exaggerated response of arginine vasopressin-enhanced green fluorescent protein fusion gene to salt loading without disturbance of body fluid homeostasis in rats. J Neuroendocrinol (2006) 0.83
Regulation of adrenocortical function by vasopressin. Horm Metab Res (1998) 0.83
Vasopressin induces breakdown of membrane phosphoinositides in adrenal glomerulosa and fasciculata cells. Endocrinology (1986) 0.83
Regulation of Ca2+ homeostasis by atypical Na+ currents in cultured human coronary myocytes. Circ Res (1999) 0.82
Evidence of two steps in the homologous desensitization of vasopressin-sensitive phospholipase C in WRK1 cells. Uncoupling and loss of vasopressin receptors. J Biol Chem (1988) 0.82
Are opioid peptides co-localized with vasopressin or oxytocin in the neural lobe of the rat? Cell Tissue Res (1986) 0.82
Micro-opioid receptor preferentially inhibits oxytocin release from neurohypophysial terminals by blocking R-type Ca2+ channels. J Neuroendocrinol (2005) 0.82
Role of Ca2+ in the action of adrenocorticotropin in cultured human adrenal glomerulosa cells. J Clin Invest (1996) 0.82
Characterization of specific V1a vasopressin-binding sites on a rat mammary-tumour-cell line. Biochem J (1986) 0.82
Angiotensin-induced changes in the apparent size of rat liver angiotensin receptors. J Recept Res (1984) 0.82
Intracellular calcium increase and somatodendritic vasopressin release by vasopressin receptor agonists in the rat supraoptic nucleus: involvement of multiple intracellular transduction signals. J Neuroendocrinol (2004) 0.82
Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla. Endocrinology (1996) 0.81
Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig. Br J Anaesth (2002) 0.81
G proteins in aortic endothelial cells and bradykinin-induced formation of nitric oxide. Eur J Pharmacol (1993) 0.81
Impaired somatodendritic responses to pituitary adenylate cyclase-activating polypeptide (PACAP) of supraoptic neurones in PACAP type I -receptor deficient mice. J Neuroendocrinol (2003) 0.81
Endothelin regulation of neuropeptide release from nerve endings of the posterior pituitary. Proc Natl Acad Sci U S A (1992) 0.81
Upregulation of V1a vasopressin receptors by glucocorticoids. Am J Physiol (1992) 0.81
Structural difference between heteromeric somatic and homomeric axonal glycine receptors in the hypothalamo-neurohypophysial system. Neuroscience (2005) 0.81
Involvement of protein kinase C in the coupling between the V1 vasopressin receptor and phospholipase C in rat glomerulosa cells: effects on aldosterone secretion. Endocrinology (1991) 0.80
Rhythmic activities of hypothalamic magnocellular neurons: autocontrol mechanisms. Biol Cell (1997) 0.80
Association of the G protein alpha(q)/alpha11-subunit with cytoskeleton in adrenal glomerulosa cells: role in receptor-effector coupling. Endocrinology (1997) 0.80
Mechanism of the antibiotic action of alpha-dehydrobiotin. Biochemistry (1980) 0.80
Specific vasopressin binding to rat adrenal glomerulosa cells. Relationship to inositol lipid breakdown. Biochem J (1986) 0.80
Size of vasopressin receptors from rat liver and kidney. Eur J Biochem (1980) 0.80
Vasopressin receptor distribution in the liver controls calcium wave propagation and bile flow. FASEB J (2001) 0.80
Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogues. J Med Chem (1991) 0.80